What is the use of umbilical cord blood in newborns?To answer this question, one can get from a range of data:
For example, more than 30 years have passed since the introduction of umbilical cord blood in Chongqing, and with the advancement of medical technology and the promotion of professionals, great progress has been made in the application of umbilical cord blood, and its efficacy has been verified in more than 100 clinical trials around the world. During this time, umbilical cord blood hematopoietic stem cell transplantation has helped more than 40,000 patients worldwide with certain cancers, blood disorders, and immune system disorders as part of stem cell transplantation.
Let's take a look at another set of data. It has been clinically proven that umbilical cord blood hematopoietic stem cell transplantation can rebuild the human hematopoietic system and immune system, and has been maturely applied to more than 80 diseases such as hematologic malignancies, hemoglobinopathies, bone marrow hematopoietic failure, inborn metabolic diseases, inborn immunodeficiency diseases, autoimmune diseases, and solid tumors. So far, there have been 80,000 cases of cord blood application in the world, and the number of cord blood applications in China has exceeded 27,000 cases.
Each set of figures fully illustrates the usefulness of umbilical cord blood in newborns, and also proves that umbilical cord blood does have broad application prospects in clinical practice and is a valuable biological resource that cannot be ignored.
Umbilical cord blood appears with the arrival of newborns, it is drawn through the umbilical vein, and is the main source of hematopoietic stem cells. Under certain conditions, hematopoietic stem cells can differentiate into other important organs and tissues of the body, and provide key support for the reconstruction of the blood and immune system. Storing the umbilical cord blood of newborns is equivalent to preserving the earliest cell information for the baby, and it is also a "backup of life" for the baby.
Newborns' umbilical cord blood does not need to be matched, and if the baby is sick, he can use his own cord blood to treat the disease, provided that it meets the indications of cord blood hematopoietic stem cells. If the baby's family is sick, this resource may also play a role, in terms of matching probability, the parents are haptagent, siblings have at least a 75% chance of being partially genetically matched, 100% of the match with identical twins, and 25% of the match between siblings. A baby's umbilical cord blood is equivalent to the future health backup of the whole family, and based on this, more and more newborn families have begun to join the ranks of cord blood storage.
Later, through further popularization, it is believed that the use of umbilical cord blood for newborns will be known to more families, and the storage of umbilical cord blood will gradually form a trend.